Skip to main content

Diagnostic options · UAE

Neurological Genetic tests in Dubai & UAE

Compare available Neurological Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

49

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetic test prices

Showing 46–49 of 49 matching tests.

Neurological Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5789
USP8 Gene NGS Test for SPG59 (Hereditary Spastic Paraplegia Type 59)

This diagnostic test evaluates the USP8 gene for variants associated with Hereditary Spastic Paraplegia Type 59 (SPG59).

Whole Blood (EDTA) or DNA (extracted) 21–28 days from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["USP8 gene variants", "Single-nucleotide variants", "Small indels", "Copy-number changes"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Suspected Hereditary Spastic Paraplegia Type 59 (SPG59)", "Family history of SPG59"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: G11.4
Clinical summary
This diagnostic test evaluates the USP8 gene for variants associated with Hereditary Spastic Paraplegia Type 59 (SPG59).
TEST-5818
WASHC5 Gene (SPG8) Genetic Test (NGS)

This test evaluates the entire coding sequence of the WASHC5 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 8 (SPG8).

Whole Blood, Extracted DNA, or FTA Card (Peripheral Blood) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WASHC5 gene sequence", "Pathogenic variants (mutations)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet changes needed prior to sample collection"]
Indications
["Suspected diagnosis of Hereditary Spastic Paraplegia type 8 (SPG8)", "Confirmation of clinical diagnosis", "Genetic counselling for affected families", "Differential diagnosis of spastic paraplegia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81246-7 ICD-10: G11.4
Clinical summary
This test evaluates the entire coding sequence of the WASHC5 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 8 (SPG8).
TEST-5750
WWOX Gene Spinocerebellar Ataxia Type 12, Autosomal Recessive Next‑Generation Sequencing (NGS) Genetic Test

This genetic test analyzes the WWOX gene to detect pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 12 (SCAR12).

Peripheral Whole Blood, Serum, or Plasma 3-4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WWOX gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions"]
Indications
["Suspected diagnosis of Spinocerebellar Ataxia Type 12 (SCAR12)", "Family history of SCAR12", "Progressive neurological symptoms consistent with SCAR12"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81658-3 ICD-10: G11.8, Z15.09, Z13.71
Clinical summary
This genetic test analyzes the WWOX gene to detect pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 12 (SCAR12).
TEST-5748
ZFYVE27 Gene SPG33 Genetic Test

This test identifies pathogenic variants within the ZFYVE27 gene associated with Hereditary Spastic Paraplegia type 33 (SPG33).

Peripheral whole blood (3–5 mL in EDTA tube), Extracted DNA (2 µg minimum, >50 ng/µL), or One Drop Blood on FTA Card. 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ZFYVE27 gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["A genetic counselling session to draw a pedigree chart of family members affected with ZFYVE27 gene SPG33 is mandatory."]
Indications
["Clinical symptoms suggestive of SPG33", "Family history of autosomal dominant inheritance of SPG33"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94719-4 ICD-10: G11.4
Clinical summary
This test identifies pathogenic variants within the ZFYVE27 gene associated with Hereditary Spastic Paraplegia type 33 (SPG33).

Category overview

Neurological Genetic: overview

Pinpointing the exact hereditary cause of a progressive movement disorder, severe neuropathy, or early-onset cognitive decline is essential for unlocking the most effective neurological care available. As a highly focused diagnostic tool in our Molecular Genetics department, Neurological Genetic testing specifically targets the exact DNA mutations responsible for your family's unique neurological challenges. By leveraging advanced sequencing technology, this precise genomic screening confirms conditions like inherited ataxias or early-onset Alzheimer's, providing the critical data necessary to assess carrier status, evaluate risks for future children, and safely guide tailored neurological interventions. Highly regarded for specialized diagnostic excellence among the best diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take control of your long-term brain health—schedule your neurological genetic testing in UAE, coordinate a comfortable home sample collection, or consult our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.